How to Buy Apellis Pharmaceuticals Stock
Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases.
Apellis Pharmaceuticals stock last closed at $20.33, up 2.62% from the previous day, and has decreased 27.55% in one year. It has overperformed other stocks in the Biotechnology industry by 0.21 percentage points. Apellis Pharmaceuticals stock is currently +26.27% from its 52-week low of $16.10, and -43.09% from its 52-week high of $35.72.
There are currently 126.53M APLS shares outstanding. The market cap of APLS is $2.57B. In the last 24 hours, 2.47M APLS shares were traded.
How to Buy Apellis Pharmaceuticals Stock
Wondering how to invest in Apellis Pharmaceuticals stock? Here's how.
- Decide where to buy Apellis Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Apellis Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Choose your payment method and add your info.
- Analyze Apellis Pharmaceuticals stock: The Apellis Pharmaceuticals ticker symbol is APLS. Is Apellis Pharmaceuticals stock a good investment? Should you buy shares of APLS? How do APLS's underlying business fundamentals look? Do top analysts think Apellis Pharmaceuticals is a good buy? Why has APLS's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if APLS is a good stock to buy).
- Execute your APLS trade: Decide if you will purchase APLS shares at the current market price or use a limit order to buy APLS shares at a given price.
- Keep tabs on your APLS position: Create a watchlist to keep tabs on your position in Apellis Pharmaceuticals stock.
Step 1: Decide where to buy Apellis Pharmaceuticals stock
You will need a brokerage account to access the NASDAQ market and buy APLS shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal info so you are able to buy APLS today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new brokerage account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have finished signing up on the best app for stock investing, you can securely and quickly fund your account:
Check out this video walkthrough to see the process of transferring money into your new brokerage account.
Step 4: Analyze Apellis Pharmaceuticals stock
After you have selected the best place to buy Apellis Pharmaceuticals stock, it's absolutely critical to analyze their stock prior to buying, so you actually understand the risk and upside.
Overview of key APLS info
Apellis Pharmaceuticals Due Diligence Score
WallStreetZen was created to help average investors perform more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on APLS's stock page.
Is APLS stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge APLS's intrinsic value.
Using relative valuations metrics:
- APLS may be undervalued based on its P/E ratio of 58.09x, relative to Biotechnology industry P/E ratio of 280.44x
- APLS may be overvalued based on its P/B ratio of 6.41x, relative to Biotechnology industry P/B ratio of 5.12x
You can access additional valuation research on APLS's stock here.
APLS Financial Health Summary
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the APLS balance sheet.
- There are more short-term assets than long-term liabilities on the APLS balance sheet.
- APLS profit margin has gone up from -35% to 4.4% in the past year.
- Total APLS debt is lower than 5 years ago, relative to shareholder equity.
Failed Health Checks:
- APLS has a relatively high debt to equity ratio of 1.64.
- APLS earnings of $91.70M is not enough to cover its interest payments.
- APLS's operating cash flow of $78.86M allows it to safely service it's debt of $475.37M.
Is it a good time to buy APLS stock, according to analysts?
Out of 13 sell side analysts who give ratings on APLS, the consensus analyst rating on APLS is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent APLS Analyst Ratings
Douglas Tsao, a top 3% analyst from HC Wainwright & Co. maintains APLS with a buy rating and lowers their APLS price target from $57.00 to $45.00, on Oct 31, 2025.
Derek Archila, a top 3% analyst from Wells Fargo upgrades APLS to a strong buy rating and raises their APLS price target from $29.00 to $32.00, on Oct 15, 2025.
Salveen Richter, a top 22% analyst from Goldman Sachs downgrades APLS to a strong sell rating and lowers their APLS price target from $26.00 to $18.00, on Sep 26, 2025.
Lisa Walter, a top 36% analyst from RBC Capital maintains APLS with a hold rating and raises their APLS price target from $17.00 to $19.00, on Aug 1, 2025.
Steve Seedhouse, a top 48% analyst from Cantor Fitzgerald maintains APLS with a strong buy rating and raises their APLS price target from $39.00 to $40.00, on Aug 1, 2025.
You can dig deeper into what analysts are forecasting on the Apellis Pharmaceuticals stock forecast page.
APLS Technicals
APLS Growth Numbers
Last year, APLS revenue was $1.02B. In the last 5 year, APLS's revenue has gone up by 335.88% per year. This was faster than the Biotechnology industry average of 41.83%.
You can research APLS's earnings and revenue performance here.
Who is buying/selling APLS?
Over the last 12 months, executives and large shareholders at APLS have sold more shares than they have bought.
Timothy Eugene Sullivan, Chief Financial Officer of APLS, was the latest APLS insider to buy. They bought $100,300.00 worth of APLS stock on Oct 21, 2025.
Research more about who owns APLS shares here.
Can I rely on APLS as an income stream?
No, Apellis Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other investors have to say about APLS?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your APLS trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a particular dollar amount, place a limit order.
Click the Open button and eToro will execute your order.
If you need more help buying stocks on eToro, click the helpful video below:
Step 6: Keep tabs on your APLS position
Now that you own some shares in APLS, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to keep tabs on your APLS stock.
APLS Feed
How to Buy Stock in Apellis Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Apellis Pharmaceuticals stock right now:
- Decide where to buy Apellis Pharmaceuticals stock
- Sign up for a brokerage account
- Deposit money your investment account
- Analyze Apellis Pharmaceuticals stock
- Execute your APLS trade
- Keep tabs on your APLS position
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get updates on your new investment in Apellis Pharmaceuticals, click the button below.
More Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.